Europe — EMA
Novaminsulfon (Metamizole Sodium Monohydrate)
GNH USA supplies Novaminsulfon (Metamizole Sodium), a non‑opioid analgesic for pain, fever, postoperative pain and colic. Request a quote for global supply.
Request sourcing
What is Metamizole Sodium Monohydrate?
Metamizole Sodium, the active ingredient in Novaminsulfon, is a pyrazolone non‑opioid analgesic presented as an oral dosage form for oral use. It is employed to treat pain, fever, postoperative discomfort and colic in adult patients under medical supervision.
GNH USA supplies Novaminsulfon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Metamizole Sodium Monohydrate used for?
Novaminsulfon (metamizole sodium) manages pain and fever by inhibiting prostaglandin synthesis.
- Pain: provides analgesic relief for acute and chronic pain conditions. - Fever: reduces elevated body temperature in febrile states. - Postoperative pain: controls discomfort following surgical procedures. - Colic: alleviates visceral pain associated with gastrointestinal colic.
What are the side effects of Metamizole Sodium Monohydrate?
Novaminsulfon may cause a range of adverse reactions, from mild to severe.
Common Side Effects: - Nausea: occasional upset stomach. - Vomiting: transient episodes after dosing. - Dizziness: mild light‑headedness. - Skin rash: mild erythema or itching. - Hypotension: temporary drop in blood pressure. - Elevated liver enzymes: mild hepatic enzyme changes.
Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells. - Anaphylaxis: life‑threatening allergic reaction. - Stevens‑Johnson syndrome: severe skin and mucous membrane disorder. - Blood dyscrasias: abnormal blood cell counts. - Severe hypotension: marked blood pressure decline. - Hepatic failure: rare liver injury.
What precautions apply to Metamizole Sodium Monohydrate?
Use of Novaminsulfon requires careful clinical assessment and monitoring.
- Blood count monitoring: assess hematology before and during therapy to detect agranulocytosis. - Renal impairment: adjust use in patients with reduced kidney function. - Hypersensitivity: avoid in individuals with known allergy to pyrazolones. - Medical supervision: administer only under prescriber guidance. - Pregnancy and lactation: safety not established; weigh risks and benefits. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.
What does Metamizole Sodium Monohydrate interact with?
Novaminsulfon can interact with several medication classes, requiring vigilance.
Major Interactions (Avoid): - Concurrent bone‑marrow suppressants: may increase risk of agranulocytosis. - Other NSAIDs: heighten gastrointestinal bleeding risk. - Anticoagulants: amplify bleeding tendencies.
Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance and electrolyte balance. - Antihypertensives: potential additive hypotensive effect. - CYP450 substrates: possible alteration of metabolism for certain drugs.



